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Background: Various risk of mortality due to hip fracture has been reported by different studies. There is scarce
controlled study on hip fracture mortality from developing countries and no data from Middle East region. The
objective of this study is to determine mortality and its risk factors one year after low trauma hip fracture.
Methods: One hundred and two patients after hip fracture not caused by high impact injuries or local bone
diseases followed up prospectively for one year. Control group consisted of sex and age matched patients
admitted to ophthalmology ward for eye surgery. Data about comorbidity obtained from both groups at baseline.
Functional state and health-related quality of life for the participants were measured using RDRS-2 and SF-36
questionnaires, respectively.
Results: The overall survival was 83% in cases and 92% in controls (log rank test 3.62, df = 1, P = 0.057). Early
mortality within the first 6 months of observation was significantly higher in patients than controls (13 in patients
vs. 2 in controls) (log rank test 8.84, df = 1, P = 0.003). The risk of mortality in the first year after fracture was
significantly and independently associated with age and baseline RDRS score. By the end of follow-up, in the
patient group, 55.4% of survivors were able to walk without any assistance and 10.8% were not able to walk.
Conclusions: The risk of mortality within the first 6 months of observation was significantly and independently
associated with low trauma hip fracture. However, age and baseline RDRS score were independent predictors of
mortality in the first year following hip fracture.Background
Hip fracture is the most serious complication of osteo-
porosis. Studies have shown that mortality increases sig-
nificantly after hip fracture and disability is high
subsequent to its occurrence [1,2]. The range of mortal-
ity risks up to one year after the fracture were reported
from 5% to 50% in various studies [2-12]. Also factors
associated with mortality is different from one study to
other one such as age, gender, presence of comorbid dis-
eases, prefracture functional ability and post fracture
complications [8,13-15]. Most epidemiologic data on hip
fracture and its consequences originate from western
countries (Scandinavian countries and North America)
with higher prevalence of this type of fracture. There are
few data from developing regions of the world and no
prospective controlled study about hip fracture outcome* Correspondence: smazloomzadeh@zums.ac.ir
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reproduction in any medium, provided the orand its associated factors from Middle East. The aim of
this study was to determine mortality and morbidity and
its risk factors after one year of follow up for patients
with hip fracture in comparison with control group
using a prospective design.
Methods
This was a prospective cohort study in which the expos-
ure was presence of hip fracture and the outcome was
mortality. Case group comprised of 102 consecutive eli-
gible patients aged ≥ 50 who admitted at Zanjan Mousavi
hospital with a low trauma hip fracture that was not
related to local bone disease or metastasis. Mousavi hos-
pital is the major referral center for trauma in Zanjan
province. Low trauma was defined as falls from standing
height or less. 41(40.2%) fractures affected the femoral
neck, and 61 (59.8%) were intertrochanteric. The frac-
tures of femoral neck was operated using Open Reduc-
tion Internal Fixation (ORIF) with 3 parallel screws or
hemiarthroplasty methods according to the age ofral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Characteristics of patient and control groupsa
Characteristics Cases (n = 102) Controls (n = 101) P-value
Age 73.7 ± 8.7 72.4 ± 9.3 0.3
BMI 23.3 ± 4.2 24.9 ± 4.5 0.03
Gender
Male 47 (46.1) 49 (48.5) 0.73
Female 55 (53.9) 52 (51.5)
Residence 0.14
Own home 95 (94.1) 89 (88.1)
Relatives home 6 (5.9) 12 (11.9)
Comorbidities
0 27 (26.5) 23 (22.8) 0.65
1-2 55 (53.9) 61 (60.4)
≥ 3 20 (19.6) 17 (16.8)
aResults expressed as mean ± standard deviation, and number (percentage) as
appropriate.
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treat those with Intertrocantheric fractures.
Control group consisted of sex and age matched (± 5 years)
patients admitted to ophthalmology ward for eye surgery
due to any cause without history of hip fracture. The major-
ity of patients in the ophthalmologic ward are at the same
age as patients with hip fracture.
Data were collected on age, residence (own home,
Relative home), concomitant diseases (Dementia, Par-
kinson, CVA, IHD or CCU admission, Hypertension,
Dyslipidemia, Diabetes, Rheumatoid arthritis and osteo-
arthritis) and drugs at baseline. BMI was calculated for
62 fracture cases and 100 controls whose data on height
and weight was available. Missing observations were due
to the inability of patients in standing on the scale for
weight measurement. Functional state and health-related
quality of life for the participants were measured by a
trained interviewer using RDRS-2 and SF-36 question-
naires that filled both at study entry and the end of fol-
low up. Functional status of hip fracture patients was
asked from themselves or their families based on their
prefracture condition. The RDRS-2 questionnaire com-
prises 18 items grouped into three domains: activities of
daily living (eight items, including eating, walking, mo-
bility, bathing, dressing, toileting, grooming, and adap-
tive tasks), degree of dependence (seven items, including
communication, hearing, sight, diet, stay in bed during
the day, incontinence, and medication), and cognitive
impairment (three items, including mental confusion,
uncooperativeness, and depression). These items are
ranked on a 4-point scale, with 0 indicating the best
function and 3 the worst. Therefore, functional status of
patient deteriorates with increasing the score of RDRS-2.
Vital status of the subjects was evaluated at 1, 3, 6,
12 months by contact via phone with the patients or
their families. The study was approved by the Ethical
Committee of the Zanjan University of Medical Sciences
and informed consent has been obtained from all
subjects.
The Kolmogorov-Smirnov test was used to evaluate
the distribution of quantitative variables. Values were
expressed as number (percentage), and mean ± standard
deviation, as appropriate. Comparisons were performed
by chi-square test for categorical variables, independent
or paired T-test for normally distributed, and Mann–
Whitney or Wilcoxon test for non-normally distributed.
The Kaplan-Meier method was used to estimate the
probability of survival at follow-up. Comparisons were
performed using the log-rank test. A Cox’s proportional
hazards model was constructed to examine the associ-
ation between mortality and the relevant variables. All
statistical analyses were performed using the SPSS PC
version 16.0 computer software program for Windows
(SPSS, Chicago, IL, USA).Results
Baseline characteristics of cases and controls are demon-
strated in Table 1. BMI was identified in 62 cases and
100 controls. The mean of BMI was lower in the cases
compared to controls (P = 0.03). No significant differ-
ences were observed between two groups for age, gen-
der, residence and number of comorbidities.
Mortality
The mean time of follow-up was 11.3 ± 2.5 (range, 1–
12 months). At the end of follow-up, 16 patients with
fracture died compared to 8 in controls. The Kaplan-
Meier survival curve indicates a greater number of
deaths in patients with fracture than controls (Figure 1).
The overall survival was 83% in cases and 92% in con-
trols (log rank test 3.62, df = 1, P = 0.057). Early mortality
or the number of deaths within the first 6 months of ob-
servation was significantly higher in patients than con-
trols (13 in patients vs. 2 in controls) (log rank test 8.84,
df = 1, P = 0.003). However, the number of deaths within
the second 6 months of follow-up was 3 in the patients
and 6 in the controls (log rank test 0.57, df = 1, P = 0.45).
The risk of mortality in the first year following hip
fracture was significantly associated with age, BMI and
baseline RDRS score using univariate Cox regression
analysis (Table 2). The hazards ratio for baseline RDRS
score remained significant after adjusting for age. In the
multivariate analysis, using age, gender, the presence of
hip fracture, and baseline RDRS score in the model, the
risk of mortality within six months was significantly and
independently higher in patients than controls (HR:
6.26, 95%CI: 1.40-28.02). However, the risk of mortality
in the first year following hip fracture was not signifi-
cantly elevated (HR: 2.07, 95%CI: 0.87-4.91). Age and
baseline RDRS score were significant and independent
Figure 1 Survival among the case and control groups.
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fracture (Table 3).Morbidity
RDRS Questionnaire scores were available for all cases
and controls at baseline and for 74 patients with fracture
and 87 controls at the end of follow-up. The mean
RDRS score in the hip fracture patients was 24.1 ± 6.4 at
baseline and 28.8 ± 9.4 at 12 months (P < 0.0001) and inTable 2 Hazard ratio and 95% confidence intervals of mortali
variables




Age (for each year increase in age) 1.08 (1.02-1.14)
Age (years)
≤ 70 1.00
> 70 4.14 (1.24- 13.89)










≥ 3 0.98 (0.34-2.82)
Baseline RDRS score 1.06 (1.02-1.11)
aAge adjusted.control group, the mean score was 24.0 ± 4.6 at baseline
and 24.6 ± 5.6 at 12 months (P = 0.71) (Figure 2).
By the end of follow-up, in the patient group, 55.4%
were able to walk without any assistance and 10.8% were
not able to walk. However, in the control group, these
proportions were 93.1% and 1.1%, respectively
(P < 0.0001).
Discussion
The present study revealed that risk of one year mor-
tality in low trauma hip fracture group is twice greater
than controls. However, the risk was not statistically
significant. Most deaths in the case group occurred in
the first 3 months after fracture (68%), however, deaths
in the control group were more frequent in the second
6 month of the year (75%). Numerous studies have
reported that mortality increased after hip fracture but
the risk varied from one study to another according to
age, sex and other characteristics of population under
study [6,12,14-25]. The risk of first year mortality
reported by Vestergaard et al. [15] and Roche et al.
[26] were 29% and 33%, respectively, which are both
higher than that of our study (15.6%). Higher mean
age and serious comorbidity such as cancer at baseline
in their patients may explain some of these differences.
The mean age of our patients at the time of fracture
(73.7 ± 8.7) was smaller than many other studiesty in the first year following hip fracture by study














0.003 1.05 (1.01-1.09) 0.028
Table 3 Hazard ratio and 95% confidence intervals of mortality within the first 6 months and in the first year
following hip fracture by study variables in multivariate analysis
Characteristics Mortality within six months Mortality in the first year
HR (95% CI) P-value HR (95% CI) P-value
Hip fracture
No 1.00 0.017 1.00 0.098
Yes 6.26 (1.40-28.02) 2.07 (0.87-4.91)
Age (for each year increase in age) 1.05 (0.98-1.13) 0.17 1.06 (1.004-1.13) 0.037
Gender
Female 1.00 0.33 1.00 0.16
Male 1.68 (0.59-4.77) 1.81 (0.79-4.18)
Baseline RDRS score 1.04 (0.99-1.09) 0.13 1.05 (1.004-1.09) 0.029
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which is one of the most important risk factor for
mortality, perhaps this subject was responsible for less
mortality after operation in our study.
We found that the Hazard ratio of early mortality
(during the first 6 months after fracture) was signifi-
cantly 6.26 times greater in fracture cases than controls.
Higher mortality during the first several months after
fracture was also reported in other studies [13,15,24].
Later mortality was varied since some studies indicated
that excess mortality continues after this time period but
others reported no excess mortality after that
[7,14,24,27].
Since there was no significant difference for the num-
ber of co-morbidities and SF 36 scores (data not
reported), both indicators of general health, between the
case and control groups, the high early mortality
observed in our study, can be perceived that hip fracture
is the primary cause of death shortly after the event.
This is in accordance to the study by Vestergaard et al.
[15], however, we did not investigate causes of death inFigure 2 RDRS at Base line and at the end of follow up in case
and control group.our study and RDRS was 2 scores worse in cases that is
not clinically important.
We found age, BMI and pre-fracture RSDS scores as
prognostic factors for mortality, in the univariate ana-
lysis. The risk of death increased with advancing age and
became more prominent after 70 years as indicated in
Table 2. Several studies have identified mortality rates
following hip fracture increases with advancing age
[7,11,19,21,28]. However, three studies have indicated
that younger age at fracture lead to excess mortality
compared to the controls and this risk decreases with
advancing age [11,14,17,23]. In our study, age was an in-
dependent risk factor for mortality in the first year fol-
lowing hip fracture, but not for early mortality (within
six months), after controlling the effect of other variables
in the multivariate analysis.
In this study, a higher proportion of hip fracture was
indicated in males compared to females. In our previous
study, the female to male ratio of hip fracture for Iranian
habitants in Zanjan province was 1.0 or less in almost all
age-groups which is lower than that was reported in
most western countries but it is similar to the low inci-
dence rate of hip fracture areas in Asia such as rural
areas in Turkey and Beijing, China [29,30]. The
complete etiology of HF in this area is not well under-
stood. The main reason for this difference is related to
lower incidence in women as the statistics shows, but
the rate of hip fracture in Iranian men resembles
recorded rate in most western countries. In this regards
the present observe confirms the results of previous
study on the epidemiology of hip fracture in Iran by
Moayyeri et al. [31]. These results are not in consistent
with low bone density demonstrated in Iranian women.
It is suggested that the incidence of fall injuries in men
is higher than women in the under 60 age group. In the
above 60 age group, the risk of incidentally falling ele-
vates dramatically in women and it is higher than men.
Interestingly, results of many suggest that breast feeding
may reduce the risk of hip fractures in women in elderly.
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explain the observed low HF incidence in the area.
Tosteson and co-workers [24], reported that in
addition to age, BMI, and pre-fracture health status, sex
is also a prognostic factor of mortality after hip fracture
but in our study sex did not influence mortality. Similar
to the findings of Tosteson, many researchers found that
males had worse outcomes than females following hip
fracture [8,32-34]. On the other hand, a few other earlier
studies concluded that gender is not an independent
predictor of mortality in multivariate analysis [2,35]. In
our analysis presence and the number of co-morbidity
did not have an effect on the one year survival and this
finding is in agreement with the results of the study con-
ducted by Cipitria et al. [36]. In contrast, the majority of
studies indicated that co-morbidities increases the risk
of mortality [14,15,19,21,23,24]. Baseline RDRS scores
that directly indicates functional ability influenced mor-
tality in our cases, with a HR of 1.06. Our analysis has
also indicated that an increase in BMI decreases mortal-
ity, an effect that is reported only in two of the previous
studies, however, missing data in our case group for
BMI was about 40% [14,24].
More than half (55%) of survivors in case group of our
study, were able to walk without any assistance, 34% could
walk with crutch or walker and 11% were bedridden.
Pande et al. [8] reported that only 36% of their patients
(males) could walk independently 12 months after frac-
ture and 15% could not walk. The proportion of those
who became bedridden was 9% in a study by Wong and
colleagues [37], which is close to our findings. The
mean age and RDRS score of patients were statistically
different according to the ability to walk after operation
(69.8 and 22.5 for those who were able to walk without
any assistance, 76.1 and 25.0 for those who were able to
walk with assistance and 73.1 and 29.8 for those who
were not able to walk, P = 0.01 and P= 0.009,
respectively).
Our study has some strength; that was a prospective
cohort with sex and age matched control group and also
the dropout rate was less than 10% in both groups.
However, data related to health and functional ability be-
fore fracture was gathered retrospectively after admis-
sion due to fracture and may be affected by the memory
of the patients (recall bias).
Conclusion
The risk of mortality within the first 6 months of obser-
vation was significantly and independently associated
with low trauma hip fracture. However, age and baseline
RDRS score were independent predictors of mortality in
the first year following hip fracture. At the end of fol-
low-up, nearly to half of patients with fracture were not
able to walk without any assistance.Competing interests
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